# PGI2 Versus Nitroglycerine for Management of Pulmonary Hypertension After Valve Surgeries

> **NCT04594629** · PHASE1 · UNKNOWN · sponsor: **Ain Shams University** · enrollment: 120 (estimated)

## Conditions studied

- Pulmonary Hypertension

## Interventions

- **DRUG:** Nitroglycerin
- **DRUG:** PGI2

## Key facts

- **NCT ID:** NCT04594629
- **Lead sponsor:** Ain Shams University
- **Sponsor class:** OTHER
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2020-11
- **Primary completion:** 2021-05
- **Final completion:** 2021-06
- **Target enrollment:** 120 (ESTIMATED)
- **Last updated:** 2020-10-20


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04594629

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04594629, "PGI2 Versus Nitroglycerine for Management of Pulmonary Hypertension After Valve Surgeries". Retrieved via AI Analytics 2026-06-25 from https://api.ai-analytics.org/clinical/NCT04594629. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*